Phase I trial of MetaMx in patients with malignant glioma

Trial Profile

Phase I trial of MetaMx in patients with malignant glioma

Planning
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2016

At a glance

  • Drugs MetaMx (Primary)
  • Indications Glioma
  • Focus Adverse reactions
  • Sponsors Arch Biopartners
  • Most Recent Events

    • 03 Feb 2016 According to an Arch Biopartners media release, this trial is expected to start by late 2016.
    • 09 Dec 2014 New trial record
    • 26 Nov 2014 Upon completion of a pre-IND meeting, it is planned to move ahead with the filing of the IND application and execution of this MetaMx Phase I trial at a single centre in the US, according to an Arch Biopartners media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top